Educating and Advocating
for People Affected by Sickle Cell
Pfizer Sickle Cell Engagement Survey
Help shape the future of future programs to help meet your needs effectively. At Pfizer, we believe that truly supporting people with sickle cell disease means seeing and understanding each unique journey. By taking this survey, you help us continue to improve as we show up, listen, and create meaningful change—because you are more than your condition.
What is Sickle Cell Disease?
Sickle Cell Disease is an inherited red blood cell disorder that causes healthy, round red blood cells to become hard, sticky, and c-shaped—just like the farm tool called a “sickle”.
Live Your Best Life
with Sickle Cell Disease
Latest News
- Novo Nordisk Announces Promising Topline HIBISCUS Study Results
by Emma Day on April 23, 2026 at 9:17 pmIn an announcement, Novo Nordisk shared that Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving hemoglobin response in sickle cell disease. The post Novo Nordisk Announces Promising Topline HIBISCUS Study Results first appeared on SCDAA.